Apellis Pharmaceuticals, Inc. (APLS) has 285 open-market insider trades by 22 insiders since 2017. The most active filer is Cedric Francois, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Morningside Venture Investments Ltd via Bihua Chen | 10% Owner | — | 6 | $50.5M | 2021-11-18 |
| Cedric Francois | CEO | — | 34 | $42.8M | 2026-05-14 |
| A. Sinclair Dunlop | Dir | — | 16 | $41.3M | 2026-01-01 |
| Hillhouse Capital Management, Ltd. | 10% Owner | — | 1 | $20.0M | 2017-11-13 |
| Pascal Deschatelets | CSO | — | 29 | $15.3M | 2026-05-14 |
| Cormorant Global Healthcare Master Fund, LP | Dir10% Owner | — | 1 | $15.0M | 2017-11-13 |
| David O. Watson | CLO | — | 23 | $7.7M | 2026-05-14 |
| Adam J. Townsend | CCO | — | 20 | $6.4M | 2025-01-29 |
| Mark Jeffrey DeLong | — | — | 27 | $5.5M | 2026-05-14 |
| Nur Nicholson | CTO | — | 12 | $4.4M | 2026-05-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark Jeffrey DeLong | Chief Business & Strat Officer | Sell | $8K | 2026-02-11 |
| Pascal Deschatelets | Chief Scientific Officer | Sell | $129K | 2026-01-22 |
| David O. Watson | General Counsel | Sell | $171K | 2026-01-22 |
| Caroline Baumal | Chief Medical Officer | Sell | $61K | 2026-01-22 |
| Cedric Francois | CEO | Sell | $592K | 2026-01-22 |
| Nur Nicholson | Chief Technical Officer | Sell | $168K |
Companies that share insiders with APLS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-01-22 |
| Timothy Eugene Sullivan | CFO | Sell | $224K | 2026-01-22 |
| Mark Jeffrey DeLong | Chief Business & Strat Officer | Sell | $73K | 2026-01-22 |
| James George Chopas | VP/Chief Accounting Officer | Sell | $45K | 2026-01-22 |
| Timothy Eugene Sullivan | CFO | Sell | $57K | 2026-01-20 |
| David O. Watson | General Counsel | Sell | $49K | 2026-01-20 |
| Pascal Deschatelets | Chief Scientific Officer | Sell | $18K | 2026-01-20 |
| Nur Nicholson | Chief Technical Officer | Sell | $44K | 2026-01-20 |
| James George Chopas | VP/Chief Accounting Officer | Sell | $14K | 2026-01-20 |
| Mark Jeffrey DeLong | Chief Business & Strat Officer | Sell | $26K | 2026-01-20 |